Cart
sales@molnova.com
Cilazapril Monohydrate
CAS No. 92077-78-6
Cilazapril Monohydrate( Ro 31-2848 monohydrate )
Catalog No. M17662 CAS No. 92077-78-6
Cilazapril Monohydrate is an angiotensin-converting enzyme (ACE) inhibitor used for the treatment of hypertension and congestive heart failure.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 52 | Get Quote |
|
| 10MG | 85 | Get Quote |
|
| 25MG | 178 | Get Quote |
|
| 50MG | 312 | Get Quote |
|
| 100MG | 583 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCilazapril Monohydrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionCilazapril Monohydrate is an angiotensin-converting enzyme (ACE) inhibitor used for the treatment of hypertension and congestive heart failure.
-
DescriptionCilazapril Monohydrate is an angiotensin-converting enzyme (ACE) inhibitor used for the treatment of hypertension and congestive heart failure.
-
In Vitro——
-
In Vivo——
-
SynonymsRo 31-2848 monohydrate
-
PathwayOthers
-
TargetOther Targets
-
RecptorACE
-
Research AreaCardiovascular Disease
-
Indication——
Chemical Information
-
CAS Number92077-78-6
-
Formula Weight435.51
-
Molecular FormulaC22H31N3O5·H2O
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 100 mg/mL; 229.62 mM
-
SMILESO.CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H]1CCCN2CCC[C@H](N2C1=O)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Paszun SK, Stanisz BJ,Gradowska A.Acta Pol Pharm. 2013 Nov-Dec;70(6):1079-85.
molnova catalog
related products
-
Thiamine nitrate
Thiamine nitrate is an essential vitamin, and can enhance normal neuronal actives.
-
Losartan Carboxylic ...
EXP-3174 is a potent AT1 antagonist (Kis: 0.57 nM, rat; 0.67 nM, human), producing a depressor response and vasodilatation.
-
(E)-SI-2
(E)-SI-2 is a potent small-molecule inhibitor of steroid receptor coactivator-3 (SRC-3 or AIB1) that can selectively inhibit the intrinsic transcriptional activities of SRC-3, also inhibits SRC-1 and SRC-2.
